AI-generated summary
The authors used an in vitro study of oocytes from a polycystic ovary model to compare exosome therapy and photobiomodulation at 640 nm with a control group. They report changes in several microRNA expression levels, along with increased glutathione and nucleus acetylation in both treated groups. As an in vitro study, the findings do not directly establish effects in people.
- Participants
- 36
- Who or what was studied
- Oocytes from a polycystic ovary syndrome model, divided into control, exosome, and photobiomodulation groups (in vitro)
- Wavelengths
- 640 nm
- Limits stated in the abstract
- The study is in vitro with 36 oocytes across three groups, so results may not apply to living humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sbmu.ac.ir.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 640 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Control group, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.